Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antiphospholipid antibodies].

Junichi Kaburaki1, Masataka Kuwana, Yasuo Ikeda

  • 1Department of Internal Medicine, Tokyo Electric Power Company(TEPCO) Hospital, Shinjuku-ku, Tokyo 160-0016, Japan.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|August 20, 2003
PubMed
Summary

Antiphospholipid syndrome (APS) is linked to antibodies targeting proteins like beta 2-glycoprotein I. Further research is needed to confirm the clinical importance of these antiphospholipid antibodies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

JCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism/Deep Vein Thrombosis.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same author

Critical ischemia of multiple organ systems in a patient with systemic lupus erythematosus complicated by catastrophic antiphospholipid syndrome: Potential pathogenetic role of non-inhibitory anti-ADAMTS13 autoantibodies.

Modern rheumatology case reports·2026
Same author

Concordance for myositis-specific autoantibody detection between commercial ELISA and line blot assays: a multicentre study conducted across the Asia-Pacific region.

Rheumatology (Oxford, England)·2026
Same author

Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study From the EUSTAR Cohort.

Arthritis care & research·2026
Same author

Transcriptomic profiling of myocardial biopsies reveals metabolic suppression and autophagy activation in systemic sclerosis-associated primary heart involvement.

Journal of scleroderma and related disorders·2026
Same author

Incidence of serious infections, herpes zoster and hepatitis B virus reactivation among patients with SLE: a cohort study using a health claims database in Japan.

Lupus science & medicine·2026

Area of Science:

  • Immunology
  • Rheumatology
  • Vascular Biology

Context:

  • Antiphospholipid syndrome (APS) is a recognized autoimmune disorder.
  • Serological markers for APS initially included anticardiolipin antibodies and lupus anticoagulants.
  • Recent research has expanded the understanding of pathogenic antiphospholipid antibodies.

Purpose:

  • To review the evolving understanding of antiphospholipid antibodies in APS.
  • To discuss the role of phospholipid-binding proteins in APS pathogenesis.
  • To highlight the preliminary Sapporo criteria for APS classification.

Summary:

  • Pathogenic antiphospholipid antibodies are increasingly recognized as targeting phospholipid-binding proteins, notably beta 2-glycoprotein I and prothrombin, in addition to phospholipids.
  • The Sapporo criteria provide a preliminary framework for diagnosing definite APS.
  • The clinical significance of these antibodies requires further prospective investigation.

Impact:

  • Advances understanding of APS immunopathogenesis.
  • May lead to refined diagnostic criteria for APS.
  • Highlights the need for continued research into antiphospholipid antibody targets and clinical relevance.

Related Experiment Videos